Find information on currently registered cell, tissue or gene therapy products (CTGTP) in Singapore.
Novartis (Singapore) Pte Ltd
Luxturna PI approved 19 April 2023
Luxturna PIL approved 20 January 2022
Yescarta PI approved 01 March 2023
Yescarta PIL approved 01 March 2023
Regulatory overview
Class 1 CTGTP notification
Register a Class 2 CTGTP
Variation applications
Dealer's notice
Dealer's licensing and certification
Report adverse events
Report or recall defective products
Clinical trials
Product consultation
Advertisements and promotions
Certificate of a Pharmaceutical Product
Guidance documents
Fees and turnaround time
Notified Class 1 CTGTP
Register of Class 2 CTGTP
Register of Licensed CTGTP Importers, Wholesalers and Manufacturers
Duties And Obligations
CTGTP applications